ARCHIVES

Partnership Points to New Path Forward For Drug Approval and Clinical Research

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

April 10, 1998

NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority

November 6, 1992

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

DCCR Receives 59 Community Hospital Oncology Program Proposals, Only here From Rural Areas

September 21, 1979

Bush Proposes $2.8 Billion Increase For NIH In FY2002, Vows $4.1B Next Year.

March 2, 2001